Due to copyright issues, an electronic copy of the thesis must be ordered from the faculty. For the faculty to have time to process the order, the order must be received by the faculty at the latest 2 days before the public defence. Orders received later than 2 days before the defence will not be processed. After the public defence, please address any inquiries regarding the thesis to the candidate.
Trial Lecture – time and place
See Trial Lecture.
Adjudication committee
- First opponent: Assistant Professor Luna Gargani, University of Pisa, Italy
- Second opponent: Professor Mai Tone Lønnebakken, University of Bergen, Norway
- Third member and chair of the evaluation committee: Professor Dan Atar, University of Oslo
Chair of the Defence
Associate Professor Lars Fjellbirkeland, University of Oslo
Principal Supervisor
Professor II Thor Edvardsen, University of Oslo
Summary
Research has highlighted a concerning prevalence of cardiac abnormalities in hospitalized COVID-19 patients.
Acute myocardial infarction remains a significant global health challenge. An enlarged left atrium in patients with myocardial infarction has shown increased mortality risk in patients with myocardial infarction for two decades ago.
The aims of the thesis were to emphasize the crucial role of echocardiography in identifying conditions that can reveal cardiac damage after COVID-19 infection and myocardial infarction which can elevate the risk of adverse outcome by doing echocardiography of patients 3 months recovery of COVID-19 and before discharge of patients with acute myocardial infarction.
Improved echocardiographic method using speckle tracking, which is a method that visualizes how the heart muscle moves and deforms, the atrial function can be measured in different phases.
The heart function of hospitalized COVID-19 patients three months recovery was minimally affected
Despite advancements in treatment for patients with myocardial infarction over the past two decades an enlarged left atrium remains as a significant prognostic factor.
The residual phase where the atrium fills with blood was together with the size of the atrium significant predictors of adverse outcome in patients with myocardial infarction.
Overall, these studies show the importance of echocardiography as a tool for early detection of heart disease. This can provide physicians with the opportunity to initiate treatment and other measures that may reduce the risk of adverse events.
Additional information
Contact the research support staff.